Global Live Cell Imaging Market to Reach About USD 15.69 billion by 2032, Aided by Increasing Research and Development (R&D) Activities

North America holds a significant share of the live cell imaging industry due to the robust healthcare sector in the region. The initiation of various research and development (R&D) activities for advancements in regenerative medicine and stem cell research is also propelling the market growth. For instance, Stanford Consortium for Regenerative Medicine partnered with Space Tango, developed a new integrated space stem cell orbital research laboratory in the International Space Station (ISS) to launch three collaborative projects in April 2020. Moreover, universal healthcare systems, such as Canadian Medicare, are increasing cost-effectiveness, adoption of various innovative techniques, and accessibility to optimal healthcare, which is further bolstering the market growth.

Some of the leading companies are Carl Zeiss AG (ETR: AFX) and Leica Microsystems GmbH. The latter announced the launch of its new live-cell correlative light and electron microscopy (CLEM) workflow solution, Leica Nano workflow, in June 2021. It is designed to surge experimental success rates, simplify light and electron microscopy integration, and improve reproducibility. It also combines high contrast live cell imaging and EM sample preparation in order to offer an all-in-one workflow for various biological interrogations. The solution provides an enhanced picture of workflows to aid healthcare professionals to gain insights into treatments and mechanisms of various issues such as neurological disorders, cancer, and viral infections, among others. It further introduces optical imaging conditions to capture cellular functional and ultrastructural information to analyse single-cell levels. Such developments and launches by the leading companies are expected to drive the market growth in the upcoming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Product Type, Application, Technology, and Region:

• The market, on the basis of product type, can be divided into equipment, consumable, and software.

• The major applications of live cell imaging are cell biology, developmental biology, and stem cell and drug discovery, among others.

• Based on technology, the industry can be divided into time-lapse microscope, fluorescence recovery after photo-bleaching (FRAP), fluorescence resonance energy transfer (FRET), and high content screening (HCS), among others.

• The regional markets for live cell imaging include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The growing use of live cell imaging techniques to analyse location, protein levels, components, and numbers of cells to be utilised in stem cell research activities is propelling the market growth.

• The market is being driven by the growing deployment of live cell imaging in the development of novel drugs.

• The development of novel technologies to precisely analyse components of proteins, nucleic acid, DNA, and RNA, among others, is aiding the market growth.

• The integration of 3D printing, artificial intelligence (AI), machine learning, and deep learning in live cell imaging to enable more precise, clearer, and easier to analyse small components of cells effectively is augmenting the growth of the industry.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for live cell imaging for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the product types, applications, technologies, and major regions of live cell imaging.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global live cell imaging market are Carl Zeiss AG, Leica Microsystems GmbH, Nikon Instruments Inc., Becton, Dickinson and Company, and GE Healthcare, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.